Literature DB >> 23413063

Infections with Pseudomonas aeruginosa in Charcot arthropathy of the foot.

Ulrich Illgner1, Andreas Uekoetter, Sabrina Runge, Hans Henning Wetz.   

Abstract

BACKGROUND: Patients with Charcot arthropathy present a high risk for ulcers with secondary bone infection. Infections with Pseudomonas aeruginosa represent a severe threat to the patients. We hypothesized that infections with P aeruginosa result in a longer stay in hospital and more operations than infections with other bacteria.
METHODS: All patients who underwent surgery for Charcot arthropathy of the feet between 1996 and 2006 (n = 205) in our clinic were included. The duration of hospitalization and number of surgeries for infections due to methicillin-resistant Staphylococcus aureus (MRSA) versus P aeruginosa were compared to infections with other bacteria. All patients were scanned for MRSA and were isolated when tested positive and treated according to a defined algorithm.
RESULTS: Seventy-nine intraoperative samples exhibited bacterial growth: 12 cases of MRSA, 14 cases of P aeruginosa, and 53 case of other bacteria. Patients with deep infections due to P aeruginosa stayed significantly longer in the hospital (52 vs 35 days, P < .041) and needed significantly more surgery (1.71 vs 1.28 surgeries, P < .027). There was no significant difference between patients with MRSA infections and those without MRSA or P aeruginosa.
CONCLUSION: Infections with P aeruginosa resulted in more surgeries and a longer stay in the hospital. Early debridement is the basic treatment. A specific algorithm for isolation and operative and antibiotic treatment for P aeruginosa infections is proposed similar to an algorithm for MRSA that has been shown to be successful. LEVEL OF EVIDENCE: Level IV, retrospective case Series.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23413063     DOI: 10.1177/1071100712464212

Source DB:  PubMed          Journal:  Foot Ankle Int        ISSN: 1071-1007            Impact factor:   2.827


  4 in total

1.  Natural Biosurfactant as Antimicrobial Agent: Strategy to Action Against Fungal and Bacterial Activities.

Authors:  Monika Choudhary; Vartika Verma; Rajendra Saran; Sameer S Bhagyawant; Nidhi Srivastava
Journal:  Cell Biochem Biophys       Date:  2022-01-04       Impact factor: 2.194

2.  High burden of diabetic foot infections in the top end of Australia: An emerging health crisis (DEFINE study).

Authors:  Robert J Commons; Claire H Robinson; David Gawler; Joshua S Davis; Ric N Price
Journal:  Diabetes Res Clin Pract       Date:  2015-09-21       Impact factor: 5.602

Review 3.  [Periprosthetic infections in systemic inflammatory rheumatic disease. Review article on diagnostics and therapy].

Authors:  U Illgner; A Uekötter; L Bause
Journal:  Z Rheumatol       Date:  2014-06       Impact factor: 1.372

4.  Clinical benefit and improvement of activity level after reconstruction surgery of Charcot feet using external fixation: 24-months results of 292 feet.

Authors:  Ulrich Illgner; Tymo Budny; Inna Frohne; Nani Osada; Jan Siewe; Hans H Wetz
Journal:  BMC Musculoskelet Disord       Date:  2014-11-22       Impact factor: 2.362

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.